Novel vaccine strategy may offer protection against flu virusesMay 19th, 2009 - 6:02 pm ICT by ANI
Washington, May 19 (ANI): Researchers at the University of Pittsburgh suggest that vaccines made up of virus-like particles (VLPs) could provide stronger and longer-lasting protection against flu viruses than conventional vaccines.
VLP vaccines can be developed and produced twice as quickly as conventional vaccines, the researchers said.
In early clinical trials, VLP vaccines appear to provide complete protection against both the H5N1 avian influenza virus and the 1918 Spanish influenza virus, said Ted Ross, an assistant professor at the University of Pittsburgh’s Center for Vaccine Research.
Adopting the new vaccine strategy may allow public health officials to respond more quickly to emerging influenza pandemics, say researchers.
The current injectable vaccine for seasonal influenza is a trivalent, inactivated vaccine. It consists of three different influenza strains that are grown in eggs and then inactivated, or killed, by chemicals that break them into tiny pieces.
Because they no longer look like the circulating virus, conventionally made vaccines strains do not elicit as strong an immune response as VLP vaccines.
VLPs can be quickly and easily produced in several ways, including growing them in cell cultures or in plants.
Also, if the genes in the disease virus are identified, then researchers can generate particles for a vaccine without an actual sample of the agent.
“The sequence for the recent H1N1 ’swine flu’ virus was online and available to scientists long before physical samples could be delivered,”
Dr. Ross said.
“It would have been possible to produce VLPs in quantity in as little as 12 weeks while conventional vaccines require physical samples of the virus and production can take approximately nine months,” he added.
The study has been presented at the 109th General Meeting of the American Society for Microbiology in Philadelphia. (ANI)
- Scientists use insect cells technology for producing swine flue vaccine - Jan 05, 2010
- Swine flu vaccine development efforts hastened worldwide following alert from WHO - Jun 03, 2009
- H1N1 pandemic flu strain 'key to universal vaccine' - Jan 11, 2011
- Virus-like particle vaccine could offer protection against chikungunya virus - Jan 29, 2010
- Maternal influenza vaccination linked to flu protection in infants - Oct 05, 2010
- 'No mutation of swine flu virus' - Apr 11, 2012
- Why H1N1 increased mortality in healthy kids? - Nov 07, 2011
- Nasal spray flu vaccine one step closer - Feb 18, 2011
- Effective antibodies against flu strains identified - Aug 10, 2012
- Universal influenza vaccine 'on the anvil' - Dec 07, 2010
- Now, a universal vaccine that kills all strains of flu virus - Feb 07, 2011
- 2009 H1N1 pandemic influenza vaccine protects mice from 1918 flu virus - Jun 16, 2010
- Human vaccine for chikungunya virus a step closer - Feb 07, 2010
- One-time jab to protect against all flu strains - Nov 16, 2010
- Swine flu spread much wider than suspected - Jun 09, 2011
Tags: american society for microbiology, cell cultures, conventional vaccines, disease virus, dr ross, flu virus, flu viruses, h5n1 avian influenza, h5n1 avian influenza virus, influenza pandemics, influenza strains, novel vaccine, physical samples, public health officials, s center, swine flu, ted ross, tiny pieces, trivalent, vaccine research